NASDAQ:HSCSW

Heart Test Laboratories Earnings Date & Estimates

Heart Test Laboratories logo
$0.08 +0.01 (+22.95%)
As of 11/18/2026 10:22 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Heart Test Laboratories is estimated to report earnings on Thursday, December 10, 2026, before market opens.

Upcoming Earnings Announcement

Announcement Date
Time
Before Market Opens

What Analysts Expect from Heart Test Laboratories

Heart Test Laboratories is expected to post earnings of -$0.62 per share on revenue of $100 thousand.

Consensus Estimates

Consensus EPS
-$0.62
Expected Revenue
$100 thousand

Prepare for the Earnings Call

Heart Test Laboratories Earnings FAQ

Heart Test Laboratories (NASDAQ:HSCSW) is estimated to report earnings on Thursday, December 10, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect Heart Test Laboratories to post earnings of -$0.62 per share for the quarter.

The consensus revenue estimate for Heart Test Laboratories is $100 thousand for the quarter.

Heart Test Laboratories Earnings Headlines

CFA: Bank of America Said THIS
On January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savings account… The digital dollar is inevitable. Think about what this means... When the digital dollar goes live, every dollar you saved could suddenly be trackable at the transaction level. Imagine the worst case scenario: You’re now subject to new digital withdrawal limits and spending restrictions. Your account can be frozen remotely without court approval. But here's what Bank of America didn't say: There's still a way to protect your wealth before this digital prison locks. While everyone else gets trapped in the digital system, my research team has been positioning members outside that reach… completely under their own control. No government tracking. No withdrawal limits. No remote freezing.tc pixel
HeartSciences to Merge with Fortitude Mining, Rebrand
See More Heart Test Laboratories Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Heart Test Laboratories? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Heart Test Laboratories and other key companies, straight to your email.

About Heart Test Laboratories

Heart Test Laboratories (NASDAQ:HSCSW), which does business as HeartSciences, is a medical technology company focused on improving the use of electrocardiograms to help identify heart disease. Its main product is the MyoVista wavECG, a 12-lead ECG device designed to analyze cardiac electrical signals for indicators of heart dysfunction that may not be apparent from a conventional ECG.

The company develops its devices and analysis technology for use by healthcare providers as tools to support cardiac assessment. HeartSciences’ work centers on applying advanced signal-processing methods to ECG data, with the aim of helping clinicians identify potential heart problems and determine whether further evaluation may be appropriate.

View Heart Test Laboratories Profile